Canopy Immuno-Therapeutics
Advancing beyond immunosuppression, Striving towards curing autoimmunity.
Haifa, Israel · Founded 2020
- Headquarters
- Haifa
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- canopy-biotech.com
About
Canopy Immuno-Therapeutics is a clinical-stage biotechnology company developing antigen-drug conjugates (AgDCs), a novel class of non-immunosuppressive biologics designed to selectively eliminate pathological antibodies and autoreactive B-cells in antibody-mediated autoimmune diseases. Founded in 2020 by Dr. Kfir Oved, a serial bio-entrepreneur with dual training in medicine and immunology, the company operates in stealth mode from Israel and uses its proprietary Reverse Immunization platform to target specific autoimmune conditions including Myasthenia Gravis without the broad immunosuppression of existing therapies. Canopy is backed by investors and affiliated with JLABS Singapore.
Summary
Canopy Immuno-Therapeutics is a Biotech company based in Haifa, Israel, founded in 2020.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...